Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal

Open access

Abstract

Introduction and Aims. As an antidepressant with sedative and anxiolytic properties, mirtazapine may be an appropriate pharmacotherapy for methamphetamine withdrawal. This study sought to examine whether mirtazapine improves retention and alleviates methamphetamine withdrawal symptoms in an out‐patient setting. Design and Methods. An out‐patient double‐blind, randomised placebo‐controlled trial of mirtazapine for the treatment of methamphetamine withdrawal was conducted (15 mg nocte for 2 days, 30 mg nocte for 12 days). Both groups were offered narrative therapy counselling. Measures recorded on days 0, 3, 7, 14 and 35 included: treatment retention, Amphetamine Cessation Symptoms Assessment, the Athens Insomnia Scale, the Brief Symptom Inventory, the Depression–Anxiety–Stress Scale (DASS), Severity of Dependence scale and the Opiate Treatment Index Drug Use subscale. Results. Thirty‐one participants were recruited (18 placebo, 13 mirtazapine) and 52% completed the 2‐week medication phase. No significant differences between the mirtazapine and placebo groups in retention, or any symptom measure were observed, except greater DASS–anxiety and longer sleep duration were measured at baseline among the mirtazapine group. Discussion and Conclusions. Results suggest that mirtazapine does not facilitate retention or recruitment in out‐patient methamphetamine withdrawal treatment, although recruitment may have been insufficient to identify a significant treatment effect. The potential role of narrative therapy for methamphetamine dependent patients deserves further exploration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/09595230801935672

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 3

  1. McGregorC.Amphetamine withdrawal: nature time course and treatment[dissertation]. Adelaide South Australia:The University of Adelaide 2005.
  2. Derogatis LR., 1993, Brief symptom inventory administration, scoring, and procedures manual
  3. 10.1111/j.1360-0443.1997.tb02953.x · doi:10.1111/j.1360-0443.1997.tb02953.x · Paper page

Cited by

Metadata

Authors
CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D.
Affiliations
  • The University of Western Australia (AU)
  • UNSW Sydney (AU)
  • Mental Health Commission (AU)
Corresponding author
CRUICKSHANK, CHRISTOPHER C.
Venue
Drug and Alcohol Review
Publisher
Wiley
Published
2008-05
Volume
27
Issue
3
Pages
326-333
ISSN
  • 0959-5236 (ISSN-L)
  • 1465-3362
OpenAlex
W2142454789
Cited by
74
References
46
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 3 · 2017: 6 · 2016: 4 · 2015: 6 · 2014: 2 · 2013: 4 · 2012: 8
FWCI
4.19
Type
journal article
Language
en
Open access
Locations
  • Drug and Alcohol Review (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords
mirtazapine, methamphetamine withdrawal, treatment retention, narrative therapy, outpatient care, antidepressants, substance dependence, anxiety, sleep duration
MeSH terms
Mirtazapine, Adult, Ambulatory Care, Central Nervous System Stimulants, Antidepressive Agents, Tricyclic, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Methamphetamine, Mianserin, Psychiatric Status Rating Scales, Severity of Illness Index, Substance Withdrawal Syndrome, Time Factors, Amphetamine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.